<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is a rare aggressive <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, which responds poorly to standard chemotherapy regimens used to treat high-grade non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) </plain></SENT>
<SENT sid="1" pm="."><plain>The use of intensive chemotherapy protocols using <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> and intensive <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> prophylaxis has dramatically altered prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>We have treated eight patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with a modified BFM protocol </plain></SENT>
<SENT sid="3" pm="."><plain>The dose of <z:chebi fb="0" ids="44185">methotrexate</z:chebi> was reduced from 5 g/m2 to 1.5 g/m2 with the aim of reducing toxicity </plain></SENT>
<SENT sid="4" pm="."><plain>Seven patients received a total of six cycles of chemotherapy each and one patient received five cycles of chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>Each cycle included high-dose <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, an <z:chebi fb="0" ids="22333">alkylating agent</z:chebi> (ifosphamide or <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>) and two triple intrathecal injections of chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients with bulky abdominal disease in addition received an autologous stem cell transplant </plain></SENT>
<SENT sid="7" pm="."><plain>The regimen was well tolerated with minimal toxicity </plain></SENT>
<SENT sid="8" pm="."><plain>At a median follow-up of 16 months (range 10-28), six of the eight patients (75%) were alive and in complete remission </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients relapsed, one 24 months post-BFM chemotherapy and the other 1-month post-autologous stem cell transplantation and 2 months post-BFM chemotherapy </plain></SENT>
</text></document>